Frontage Laboratories Executive and Leadership Team

Zhongping Lin, the Co-Chief Executive Officer at Frontage Laboratories, directs the overarching corporate strategy and long-term vision. This leadership role involves guiding the company's expansion and ensuring alignment with its mission to support pharmaceutical and biotechnology clients in achieving their product development objectives. Lin oversees the integration of diverse service offerings, from drug discovery through to regulatory submissions, ensuring a seamless client experience. The Co-Chief Executive Officer's focus extends to fostering innovation within the organization and maintaining Frontage Laboratories' position as a leading CRO. By driving strategic partnerships and resource allocation, Zhongping Lin ensures the company's continued growth and impact on global drug development. This executive's purview encompasses all facets of the business, aiming to accelerate the advancement of novel therapeutics through comprehensive scientific and operational support.

Huan Wang, the Interim Chief Financial Officer at Frontage Laboratories, manages the company's financial operations and fiscal strategy. This role involves overseeing budgeting, financial planning, and reporting to ensure the economic health and sustainability of the organization. Wang guides financial decision-making, supporting the company's mission to provide integrated, science-driven product development services to the pharmaceutical and biotechnology sectors. The Interim Chief Financial Officer's oversight extends to managing capital resources, optimizing financial performance, and ensuring compliance with all financial regulations. By maintaining robust financial controls and strategic fiscal management, Huan Wang enables Frontage Laboratories to invest in critical research and development capabilities, thereby supporting client goals for advancing molecules through development and filing regulatory submissions. This executive's leadership ensures the financial stability necessary for continued operational excellence and global market reach.

Min Wang, the Chief Operating Officer at Frontage Laboratories, executes the operational framework that supports integrated drug development services. This executive oversees the day-to-day management of critical functions including bioanalysis, preclinical safety and toxicology assessment, and early phase clinical studies. Wang ensures operational efficiency and quality across all service lines, directly impacting the company's ability to deliver comprehensive solutions to pharmaceutical and biotechnology clients. The Chief Operating Officer's responsibilities include optimizing laboratory processes, managing scientific teams, and ensuring compliance with regulatory standards in the United States, China, and other key markets. By driving operational excellence, Min Wang facilitates the advancement of molecules through development pipelines, contributing significantly to client regulatory submissions. This leadership position is vital for maintaining the high standards of scientific rigor and service delivery that define Frontage Laboratories.

Abdul Mutlib, the Scientific Strategy Chief & Officer & President, Canada at Frontage Laboratories, spearheads the strategic direction of scientific initiatives and oversees operations in Canada. This executive's purview includes guiding the integration of advanced scientific services, such as drug metabolism and pharmacokinetics, analytical testing, and formulation development, to meet client development goals. Mutlib ensures that Frontage Laboratories remains at the forefront of scientific innovation, driving the advancement of novel therapeutics. The Scientific Strategy Chief & Officer & President, Canada's responsibilities encompass fostering scientific collaboration, identifying emerging research trends, and ensuring the highest standards of scientific execution across all service lines. By leading the Canadian operations and shaping scientific strategy, Abdul Mutlib significantly contributes to the company's ability to support global regulatory submissions and accelerate the journey of molecules from discovery to market. This leadership role is critical for maintaining Frontage Laboratories' reputation for scientific excellence and comprehensive product development support.